Selected research
Industry Research
General Anesthetic for Surgery Industry Research Report 2026
Market perspective
The global General Anesthetic for Surgery market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for General Anesthetic for Surgery is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for General Anesthetic for Surgery is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for General Anesthetic for Surgery is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of General Anesthetic for Surgery include Yichang Humanwell, Xi'an Libang, Nhwa, Hengrui, Fresenius-Kabi, B.Braun, Baxter Healthcare, AbbVie and Piramal, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global General Anesthetic for Surgery market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
General Anesthetic for Surgery Market by Company
Yichang Humanwell
Xi'an Libang
Nhwa
Hengrui
Fresenius-Kabi
B.Braun
Baxter Healthcare
AbbVie
Piramal
Maruishi
Hikma Pharmaceuticals
Aspen Pharma
General Anesthetic for Surgery Segment by Type
Isoflurane
Etomidate
Remifentanil
Sevoflurane
Propofol
Other
General Anesthetic for Surgery Segment by Application
Intravenous Anesthetics
Inhalational Anesthetics
General Anesthetic for Surgery Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global General Anesthetic for Surgery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of General Anesthetic for Surgery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of General Anesthetic for Surgery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of General Anesthetic for Surgery manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of General Anesthetic for Surgery by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of General Anesthetic for Surgery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Isoflurane
- Etomidate
- Remifentanil
- Sevoflurane
- Propofol
- Other
Applications
- Intravenous Anesthetics
- Inhalational Anesthetics
Companies covered
- Yichang Humanwell
- Xi'an Libang
- Nhwa
- Hengrui
- Fresenius-Kabi
- B.Braun
- Baxter Healthcare
- AbbVie
- Piramal
- Maruishi
- Hikma Pharmaceuticals
- Aspen Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global General Anesthetic for Surgery Market Size (2021-2032)
- 2.2.2 Global General Anesthetic for Surgery Sales (2021-2032)
- 2.2.3 Global General Anesthetic for Surgery Market Average Price (2021-2032)
- 2.3 General Anesthetic for Surgery by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Isoflurane
- 2.3.3 Etomidate
- 2.3.4 Remifentanil
- 2.3.5 Sevoflurane
- 2.3.6 Propofol
- 2.3.7 Other
- 2.4 General Anesthetic for Surgery by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Intravenous Anesthetics
- 2.4.3 Inhalational Anesthetics
3 Market Competitive Landscape by Manufacturers
- 3.1 Global General Anesthetic for Surgery Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global General Anesthetic for Surgery Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global General Anesthetic for Surgery Revenue of Manufacturers (2021-2026)
- 3.4 Global General Anesthetic for Surgery Average Price by Manufacturers (2021-2026)
- 3.5 Global General Anesthetic for Surgery Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of General Anesthetic for Surgery, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of General Anesthetic for Surgery, Product Type & Application
- 3.8 Global Manufacturers of General Anesthetic for Surgery, Established Date
- 3.9 Global General Anesthetic for Surgery Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yichang Humanwell
- 4.1.1 Yichang Humanwell Company Information
- 4.1.2 Yichang Humanwell Business Overview
- 4.1.3 Yichang Humanwell General Anesthetic for Surgery Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yichang Humanwell General Anesthetic for Surgery Product Portfolio
- 4.1.5 Yichang Humanwell Recent Developments
- 4.2 Xi'an Libang
- 4.2.1 Xi'an Libang Company Information
- 4.2.2 Xi'an Libang Business Overview
- 4.2.3 Xi'an Libang General Anesthetic for Surgery Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Xi'an Libang General Anesthetic for Surgery Product Portfolio
- 4.2.5 Xi'an Libang Recent Developments
- 4.3 Nhwa
- 4.3.1 Nhwa Company Information
- 4.3.2 Nhwa Business Overview
- 4.3.3 Nhwa General Anesthetic for Surgery Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Nhwa General Anesthetic for Surgery Product Portfolio
- 4.3.5 Nhwa Recent Developments
- 4.4 Hengrui
- 4.4.1 Hengrui Company Information
- 4.4.2 Hengrui Business Overview
- 4.4.3 Hengrui General Anesthetic for Surgery Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hengrui General Anesthetic for Surgery Product Portfolio
- 4.4.5 Hengrui Recent Developments
- 4.5 Fresenius-Kabi
- 4.5.1 Fresenius-Kabi Company Information
- 4.5.2 Fresenius-Kabi Business Overview
- 4.5.3 Fresenius-Kabi General Anesthetic for Surgery Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Fresenius-Kabi General Anesthetic for Surgery Product Portfolio
- 4.5.5 Fresenius-Kabi Recent Developments
- 4.6 B.Braun
- 4.6.1 B.Braun Company Information
- 4.6.2 B.Braun Business Overview
- 4.6.3 B.Braun General Anesthetic for Surgery Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 B.Braun General Anesthetic for Surgery Product Portfolio
- 4.6.5 B.Braun Recent Developments
- 4.7 Baxter Healthcare
- 4.7.1 Baxter Healthcare Company Information
- 4.7.2 Baxter Healthcare Business Overview
- 4.7.3 Baxter Healthcare General Anesthetic for Surgery Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Baxter Healthcare General Anesthetic for Surgery Product Portfolio
- 4.7.5 Baxter Healthcare Recent Developments
- 4.8 AbbVie
- 4.8.1 AbbVie Company Information
- 4.8.2 AbbVie Business Overview
- 4.8.3 AbbVie General Anesthetic for Surgery Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 AbbVie General Anesthetic for Surgery Product Portfolio
- 4.8.5 AbbVie Recent Developments
- 4.9 Piramal
- 4.9.1 Piramal Company Information
- 4.9.2 Piramal Business Overview
- 4.9.3 Piramal General Anesthetic for Surgery Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Piramal General Anesthetic for Surgery Product Portfolio
- 4.9.5 Piramal Recent Developments
- 4.10 Maruishi
- 4.10.1 Maruishi Company Information
- 4.10.2 Maruishi Business Overview
- 4.10.3 Maruishi General Anesthetic for Surgery Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Maruishi General Anesthetic for Surgery Product Portfolio
- 4.10.5 Maruishi Recent Developments
- 4.11 Hikma Pharmaceuticals
- 4.11.1 Hikma Pharmaceuticals Company Information
- 4.11.2 Hikma Pharmaceuticals Business Overview
- 4.11.3 Hikma Pharmaceuticals General Anesthetic for Surgery Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hikma Pharmaceuticals General Anesthetic for Surgery Product Portfolio
- 4.11.5 Hikma Pharmaceuticals Recent Developments
- 4.12 Aspen Pharma
- 4.12.1 Aspen Pharma Company Information
- 4.12.2 Aspen Pharma Business Overview
- 4.12.3 Aspen Pharma General Anesthetic for Surgery Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Aspen Pharma General Anesthetic for Surgery Product Portfolio
- 4.12.5 Aspen Pharma Recent Developments
5 Global General Anesthetic for Surgery Market Scenario by Region
- 5.1 Global General Anesthetic for Surgery Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global General Anesthetic for Surgery Sales by Region: 2021-2032
- 5.2.1 Global General Anesthetic for Surgery Sales by Region: 2021-2026
- 5.2.2 Global General Anesthetic for Surgery Sales by Region: 2027-2032
- 5.3 Global General Anesthetic for Surgery Revenue by Region: 2021-2032
- 5.3.1 Global General Anesthetic for Surgery Revenue by Region: 2021-2026
- 5.3.2 Global General Anesthetic for Surgery Revenue by Region: 2027-2032
- 5.4 North America General Anesthetic for Surgery Market Facts & Figures by Country
- 5.4.1 North America General Anesthetic for Surgery Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America General Anesthetic for Surgery Sales by Country (2021-2032)
- 5.4.3 North America General Anesthetic for Surgery Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe General Anesthetic for Surgery Market Facts & Figures by Country
- 5.5.1 Europe General Anesthetic for Surgery Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe General Anesthetic for Surgery Sales by Country (2021-2032)
- 5.5.3 Europe General Anesthetic for Surgery Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific General Anesthetic for Surgery Market Facts & Figures by Country
- 5.6.1 Asia Pacific General Anesthetic for Surgery Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific General Anesthetic for Surgery Sales by Country (2021-2032)
- 5.6.3 Asia Pacific General Anesthetic for Surgery Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America General Anesthetic for Surgery Market Facts & Figures by Country
- 5.7.1 South America General Anesthetic for Surgery Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America General Anesthetic for Surgery Sales by Country (2021-2032)
- 5.7.3 South America General Anesthetic for Surgery Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa General Anesthetic for Surgery Market Facts & Figures by Country
- 5.8.1 Middle East and Africa General Anesthetic for Surgery Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa General Anesthetic for Surgery Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa General Anesthetic for Surgery Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global General Anesthetic for Surgery Sales by Type (2021-2032)
- 6.1.1 Global General Anesthetic for Surgery Sales by Type (2021-2032) & (k units)
- 6.1.2 Global General Anesthetic for Surgery Sales Market Share by Type (2021-2032)
- 6.2 Global General Anesthetic for Surgery Revenue by Type (2021-2032)
- 6.2.1 Global General Anesthetic for Surgery Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global General Anesthetic for Surgery Revenue Market Share by Type (2021-2032)
- 6.3 Global General Anesthetic for Surgery Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global General Anesthetic for Surgery Sales by Application (2021-2032)
- 7.1.1 Global General Anesthetic for Surgery Sales by Application (2021-2032) & (k units)
- 7.1.2 Global General Anesthetic for Surgery Sales Market Share by Application (2021-2032)
- 7.2 Global General Anesthetic for Surgery Revenue by Application (2021-2032)
- 7.2.1 Global General Anesthetic for Surgery Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global General Anesthetic for Surgery Revenue Market Share by Application (2021-2032)
- 7.3 Global General Anesthetic for Surgery Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 General Anesthetic for Surgery Value Chain Analysis
- 8.1.1 General Anesthetic for Surgery Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 General Anesthetic for Surgery Production Mode & Process
- 8.2 General Anesthetic for Surgery Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 General Anesthetic for Surgery Distributors
- 8.2.3 General Anesthetic for Surgery Customers
9 Global General Anesthetic for Surgery Analyzing Market Dynamics
- 9.1 General Anesthetic for Surgery Industry Trends
- 9.2 General Anesthetic for Surgery Industry Drivers
- 9.3 General Anesthetic for Surgery Industry Opportunities and Challenges
- 9.4 General Anesthetic for Surgery Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst